EUCTR2013-002123-41-NO进行中(未招募)不适用
Effects of intraarticular IL1-Ra on pain and inflammatory mediators after knee arthroscopy –a double blind, placebo controlled study using microdialysis technique
ovisenberg Diaconal Hospital0 个研究点开始时间: 2013年7月29日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Otherwise healthy patients between 18 and 70 years undergoing diagnostic or therapeutic knee arthroscopy.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 60
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 15
排除标准
- •1.Pregnancy or lactation
- •2.Established osteoarthritis or synovitis
- •3.Known intolerance to anakinra
- •4.Kidney failure (Creatinine clearance <30ml/min)
- •5.History of frequent infectious diseases or immunodeficiency
- •6.Heart failure
- •7.History of drug –or alcohol abuse
- •8.Participation in other synchronous clinical trials
- •9.Perioperative steroidtreatment, perioperative acetaminophen (12 hrs), NSAIDs (24 hrs) or COX2-inhibitors (48 hrs).
- •10.Use of tourniquet for bloodless field
- •11.Strong preoperative pain
- •12.Intolerable postoperative pain (VRS=4)
研究者
相似试验
撤回
4 期
Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee ArhroscopyKnee InjuriesNCT01997138Oslo University Hospital
已完成
不适用
Effects of Interleukin-1 Inhibition on Vascular and Left Ventricular Function in Rheumatoid Arthritis Patients With Coronary Artery DiseaseRheumatoid ArthritisInflammationCoronary Artery DiseaseNCT01566201University of Athens80
进行中(未招募)
不适用
Anakinra to treat a gout attackEUCTR2014-000173-39-NLJan van Breemen Research Institute Reade and VU University Medical Centre
招募中
不适用
The effect of IL-1 inhibition by anakinra in acute gout;- A proof of concept studyGout.10023213NL-OMON40227Jan van Breemen Instituut20
已完成
不适用
Effect of Interleukin-1 receptor antagonist on insulin sensitivity in obese, insulin resistant individualsmaturity-onset diabetestype 2 diabetes mellitus10018424NL-OMON33714niversitair Medisch Centrum Sint Radboud12
